V J Ferrans
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiomyopathy and Myosin Studies
- Cardiac Valve Diseases and Treatments
- Pulmonary and Respiratory Medicine top 0.5%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Neonatal Respiratory Health Research
- Inhalation and Respiratory Drug Delivery
- Medical Imaging and Pathology Studies
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 22
- Cardiomyopathy and Myosin Studies 12
- Cardiac Valve Diseases and Treatments 11
- Cardiovascular Function and Risk Factors 9
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 16
- Neonatal Respiratory Health Research 12
- Co-authors
- Ronald G. Crystal (19 shared papers)Oichi Kawanami (14 shared papers)Gary W. Hunninghake (5 shared papers)Erik Herman (18 shared papers)William C. Roberts (11 shared papers)James E. Gadek (2 shared papers)Zu‐Xi Yu (6 shared papers)John F. Van Vleet (4 shared papers)
- Journals
- Circulation (11 papers)Journal of Molecular and Cellular Cardiology (9 papers)Journal of Clinical Investigation (5 papers)Cancer Chemotherapy and Pharmacology (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
V J Ferrans
140 papers receiving 8.5k citations
V J Ferrans's Hit Papers
Peers
Comparison fields: 5 of 155
- Cardiology and Cardiovascular Medicine 2.6k
- Pulmonary and Respiratory Medicine 2.6k
- Immunology 1.1k
- Immunology and Allergy 264
- Oncology 1.2k
Countries citing papers authored by V J Ferrans
This map shows the geographic impact of V J Ferrans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V J Ferrans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V J Ferrans more than expected).
Fields of papers citing papers by V J Ferrans
This network shows the impact of papers produced by V J Ferrans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V J Ferrans. The network helps show where V J Ferrans may publish in the future.
Co-authors
The 25 scholars most cited alongside V J Ferrans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Hit paper breakdown → | 1979 | 807 |
| 2 | Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Hit paper breakdown → | 1996 | 507 |
| 3 | 1986 | 282 | |
| 4 | 1992 | 264 | |
| 5 | Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. | 1996 | 204 |
| 6 | Intraluminal fibrosis in interstitial lung disorders. | 1986 | 202 |
| 7 | 1991 | 191 | |
| 8 | 1981 | 189 | |
| 9 | 1984 | 180 | |
| 10 | Overview of cardiac pathology in relation to anthracycline cardiotoxicity. | 1978 | 180 |
| 11 | Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. | 1998 | 174 |
| 12 | Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. | 1975 | 171 |
| 13 | Structure of alveolar epithelial cells in patients with fibrotic lung disorders. | 1982 | 170 |
| 14 | 1987 | 162 | |
| 15 | 1989 | 161 | |
| 16 | Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation. | 1983 | 143 |
| 17 | Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants. | 1980 | 143 |
| 18 | 1985 | 139 | |
| 19 | Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. | 1985 | 139 |
| 20 | 1998 | 130 |
About V J Ferrans
V J Ferrans is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Physiology, having authored 140 papers that have together received 9.1k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Neonatal Respiratory Health Research (12 papers), Cardiomyopathy and Myosin Studies (12 papers), Cardiac Valve Diseases and Treatments (11 papers), Cancer Treatment and Pharmacology (10 papers), Cardiovascular Function and Risk Factors (9 papers) and Cell Adhesion Molecules Research (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.6k citations), Pulmonary and Respiratory Medicine (2.6k citations), Immunology (1.1k citations), Immunology and Allergy (264 citations) and Oncology (1.2k citations). V J Ferrans has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Ronald G. Crystal, Oichi Kawanami, Gary W. Hunninghake, Erik Herman, William C. Roberts, James E. Gadek, Zu‐Xi Yu, John F. Van Vleet, Toren Finkel and Thomas M. Johnson. Their work appears in journals such as Circulation, Journal of Molecular and Cellular Cardiology, Journal of Clinical Investigation, Cancer Chemotherapy and Pharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.